Daily Management, Symptom Control & The Care Team
At a Glance
Familial Alzheimer-like prion disease has no cure, so daily care focuses on personalized symptom relief, swallowing and fall safety, coordinated neurology and palliative support, emergency planning, and early goals-of-care discussions.
While receiving a diagnosis of familial Alzheimer-like prion disease is deeply challenging, it marks the beginning of a shift from searching for answers to focusing on your loved one’s comfort. Although there is currently no cure, specialized palliative care—medical care focused on relieving symptoms rather than curing the underlying disease—is a crucial component of management [1][2]. Palliative care can continue alongside active neurology and rehabilitation.
Managing Symptoms at Home
Because genetic prion diseases can affect everything from movement to mood, your doctor may consider a combination of medications to keep your loved one comfortable. Because these diseases are rare, there is no “one-size-fits-all” regimen; treatment is highly individualized, and you should never start, stop, or change doses without explicit clinician guidance [1][3].
- Motor Symptoms: For muscle jerks (myoclonus) or stiffness (parkinsonism), medications such as benzodiazepines (like clonazepam) or anticonvulsants (like sodium valproate) may be considered by the treating clinician [1][4]. Warning: These drugs can cause heavy sedation, falls, confusion, dependence, and respiratory suppression. While typical Parkinson’s drugs (like levodopa) lack broad evidence, a supervised trial may be reasonable in selected parkinsonian syndromes [5].
- Neuropsychiatric Symptoms: If your loved one experiences severe anxiety, agitation, or hallucinations, low doses of antipsychotics or benzodiazepines are sometimes utilized [1]. Warning: Antipsychotics have additional dementia-related mortality and cardiovascular warnings; drug choice and dosing depend heavily on swallowing status, alertness, and goals of care.
- Autonomic Issues: In mutations like Y157X, your team may need to manage non-brain symptoms such as chronic nausea, digestive issues, or sudden drops in blood pressure when standing (postural hypotension) [6][7].
Building Your Care Team
Managing this condition requires a village. A multidisciplinary team ensures that all aspects of the disease—physical, emotional, and genetic—are addressed [8].
- Neurologist or Neurogeneticist: Ideally someone with experience in prion diseases to oversee the medical course.
- Palliative Care Specialist: They focus on “quality of life” and help manage pain, sleep, and the emotional toll on both the patient and caregiver [2].
- Physical and Occupational Therapists, and Social Work: Help with home safety, mobility, driving considerations, respite care, and social support.
- Speech-Language Pathologist (SLP): This is a critical team member who evaluates swallowing (dysphagia). They recommend individualized food and liquid strategies, positioning, and oral care. Note that thickened liquids do not eliminate the risk of aspiration pneumonia, and they can reduce enjoyment and hydration [9].
- Genetic Counselor: Essential for helping other family members understand their own risks and options for testing [10][11].
Knowing When to Call for Emergency Help
As the disease progresses, it can be difficult to tell the difference between “normal” decline and a genuine medical emergency. While gradual decline is expected, new, worsening, or distressing symptoms should be reported to the clinical team, as they may indicate a treatable condition like dehydration, pain, or medication side effects.
What is a Medical Emergency?
These situations require immediate medical assessment:
- Aspiration or Airway Issues: If your loved one is choking severely, unable to protect their airway, or develops a sudden fever and “wet” sounding cough (signs of aspiration pneumonia) [12][9].
- New or Severe Seizures: Any first-time seizure or a seizure that lasts longer than five minutes or repeats without the person waking up in between [13][4].
- Sudden, Rapid Change: A sudden inability to maintain intake, severe medication reactions, or a dramatic drop in ability over just a few hours [13][14].
What is Routine Progression?
These changes are expected parts of the disease, though you should still notify your neurologist:
- Gradual worsening of memory or confusion over weeks or months.
- Slowly increasing difficulty with walking, balance, or coordination.
- The appearance of occasional muscle jerks or “twitches” (myoclonus).
Planning for the Future
Because cognitive decline can happen more quickly than expected, establishing advance directives early is one of the most empowering things a family can do [8][2]. Discussing goals of care—such as preferences for feeding tubes, hospitalization, or hospice (whose eligibility depends on goals and prognosis rather than a fixed point)—ensures that your loved one’s wishes are honored even when they can no longer speak for themselves [2][15].
Common questions in this guide
How is familial Alzheimer-like prion disease managed day to day?
What can help with muscle jerks, stiffness, anxiety, or hallucinations?
Who should be part of the care team?
How can we reduce swallowing and aspiration risks?
Which symptoms require immediate emergency help?
When should palliative care or hospice be discussed?
Why should we make advance directives and discuss goals of care early?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which symptoms should we prioritize treating now—myoclonus, anxiety, or motor stiffness—and what medications do you recommend for them?
- 2.Can we have a speech-language pathologist perform a swallowing assessment to establish a 'baseline' and prevent aspiration?
- 3.At what point should we consider transitioning from outpatient neurology to home-based palliative care or hospice?
- 4.What is the risk of my loved one developing seizures, and should we have 'rescue medications' on hand at home?
- 5.If an emergency occurs, should we go to the nearest ER or contact your team first?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Prion diseases motor and neuropsychiatric symptom cluster pharmacotherapy: structured scoping review.
Hogg R, Centola J, McDermott EA, et al.
BMJ supportive & palliative care 2024; (14(e3)):e2397-e2410 doi:10.1136/spcare-2024-005027.
PMID: 39060092 - 2
Palliative Care Resource Utilization in Patients With Prion Disease.
Zayat R, Piura YD, Appleby BS, et al.
Neurology 2025; (105(6)):e214076 doi:10.1212/WNL.0000000000214076.
PMID: 40893060 - 3
Insights into the Diagnosis, Treatment, and Management of Prion Diseases.
Callista VA, Hatware KV, Ingle PV
CNS & neurological disorders drug targets 2026; (25(1)):25-38 doi:10.2174/0118715273381241250620114740.
PMID: 40635224 - 4
Gerstmann-Sträussler-Scheinker disease: A case report.
Zhao MM, Feng LS, Hou S, et al.
World journal of clinical cases 2019; (7(3)):389-395 doi:10.12998/wjcc.v7.i3.389.
PMID: 30746381 - 5
Dopaminergic neurodegeneration in Gerstmann-Sträussler-Scheinker (P102L) disease: insights from imaging and pathological examination.
Irie KI, Honda H, Tateishi T, et al.
Frontiers in neurology 2024; (15()):1452709 doi:10.3389/fneur.2024.1452709.
PMID: 39376689 - 6
A new prion disease: relationship with central and peripheral amyloidoses.
Mead S, Reilly MM
Nature reviews. Neurology 2015; (11(2)):90-7 doi:10.1038/nrneurol.2014.263.
PMID: 25623792 - 7
Fatal familial insomnia and Agrypnia Excitata: Autonomic dysfunctions and pathophysiological implications.
Baldelli L, Provini F
Autonomic neuroscience : basic & clinical 2019; (218()):68-86 doi:10.1016/j.autneu.2019.02.007.
PMID: 30890351 - 8
Rapid Neurocognitive Deterioration and Mortality in a Healthcare Professional With Spongiform Encephalopathy: Implications for Neurologic and End-of-Life Care.
Kortz MW, Kongs BM, Middleton LE
Cureus 2021; (13(4)):e14277 doi:10.7759/cureus.14277.
PMID: 33959455 - 9
Swallowing Function Evaluation in a Patient with Gerstmann-Sträussler-Scheinker Disease with Pro105Leu: A Case Report.
Nakane A, Hasegawa S, Ishii M, et al.
International journal of environmental research and public health 2021; (18(18)) doi:10.3390/ijerph18189734.
PMID: 34574659 - 10
Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know.
Schwartz M, Brandel JP, Babonneau ML, et al.
Frontiers in genetics 2019; (10()):895 doi:10.3389/fgene.2019.00895.
PMID: 31616476 - 11
Genetic counseling for prion disease: Updates and best practices.
Goldman JS, Vallabh SM
Genetics in medicine : official journal of the American College of Medical Genetics 2022; (24(10)):1993-2003 doi:10.1016/j.gim.2022.06.003.
PMID: 35819418 - 12
Clinicopathological findings of a long-term survivor of V180I genetic Creutzfeldt-Jakob disease.
Hayashi Y, Iwasaki Y, Waza M, et al.
Prion 2020; (14(1)):109-117 doi:10.1080/19336896.2020.1739603.
PMID: 32178563 - 13
CJD mimics and chameleons.
Mead S, Rudge P
Practical neurology 2017; (17(2)):113-121 doi:10.1136/practneurol-2016-001571.
PMID: 28153848 - 14
Clinical and Radiological Deterioration in a Case of Creutzfeldt-Jakob Disease following SARS-CoV-2 Infection: Hints to Accelerated Age-Dependent Neurodegeneration.
Ciolac D, Racila R, Duarte C, et al.
Biomedicines 2021; (9(11)) doi:10.3390/biomedicines9111730.
PMID: 34829958 - 15
Gastrostomy in patients with prion disease.
Iwasaki Y, Mori K, Ito M, et al.
Prion 2017; (11(3)):186-194 doi:10.1080/19336896.2017.1306164.
PMID: 28509623
This page is for informational purposes only and does not constitute medical advice. For medication changes, swallowing or emergency concerns, and palliative or hospice decisions, consult your loved one's neurology and care team.
Get notified when new evidence is published on Familial Alzheimer-like prion disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.